The Biden administration is aiming to improve access to life-saving medications for Americans struggling with opioid addiction. Despite the availability of effective treatments like buprenorphine and methadone, stigma and government regulations prevent 90% of those addicted to opioids from accessing these medications. Acknowledging these barriers, the administration is moving to reform rules for opioid treatment programs, making it easier for individuals to receive medications and reducing the need for daily clinic visits. These changes, initiated during the COVID-19 pandemic, have shown positive outcomes, including improved treatment retention and outcomes. While these reforms are seen as a step forward, further changes requiring congressional action are deemed necessary to fully integrate opioid addiction treatments into mainstream healthcare. Click here for article.
The Biden administration is addressing barriers to accessing life-saving medications for opioid addiction.
Stigma and government regulations currently prevent 90% of those addicted to opioids from accessing effective treatments.
Reforms to opioid treatment programs aim to make medications more accessible and reduce daily clinic visits.
Changes initiated during the pandemic have shown positive outcomes, but further reforms requiring congressional action are needed for full integration into mainstream healthcare.
Comments